SMS Lifesciences India Limited

NSE SMSLIFE.NS

SMS Lifesciences India Limited Free Cash Flow Yield on February 06, 2025: 0.94%

SMS Lifesciences India Limited Free Cash Flow Yield is 0.94% on February 06, 2025, a 0.00% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.

SMS Lifesciences India Limited 52-week high Free Cash Flow Yield is 1.79% on May 13, 2024, which is 90.00% above the current Free Cash Flow Yield.
SMS Lifesciences India Limited 52-week low Free Cash Flow Yield is 0.00% on March 28, 2024, which is -100.00% below the current Free Cash Flow Yield.
SMS Lifesciences India Limited average Free Cash Flow Yield for the last 52 weeks is 0.98%.

Key data

Date	Free Cash Flow Yield	Market Value Added (MVA)	Price to Book Ratio (P/B)	Price to Earnings Ratio (P/E)

NSE: SMSLIFE.NS

SMS Lifesciences India Limited

CEO	Mr. Talluri Veera Venkata Satyanarayana Murthy
IPO Date	Aug. 18, 2017
Location	India
Headquarters	Plot No. 19-III
Employees	574
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Perfumes & Fragrances Personal Care Plastics

Description

SMS Lifesciences India Limited manufactures, buys, imports, and sells active pharmaceutical ingredients (API) and its intermediates, organic and inorganic chemicals, and pharmaceuticals in India. The company offers APIs in various therapeutic areas, such as antiulcer, antifungal, and erectile dysfunction. It also provides consultancy services. The company exports its products. The company was founded in 1990 and is based in Hyderabad, India.

Key trends

Past 5 years